Loading clinical trials...
Loading clinical trials...
The COVID-19 pandemic exacerbates health problems by reducing access to adapted and advanced physical rehabilitation for several people who need rehabilitation services, including the population with ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Université du Québec à Chicoutimi
NCT07486934 · Myotonic Dystrophy Type 1 (DM1), DM1, and more
NCT06809049 · Myotonic Dystrophy, Congenital, Myotonic Dystrophy, Type 1 (DM1), and more
NCT06708468 · Neuromuscular Diseases (NMD), Charcot Marie Tooth Disease (CMT), and more
NCT05027269 · DM1, Myotonic Dystrophy 1, and more
NCT05560438 · Myotonic Dystrophy Type 1 (DM1)
Groupe de recherche interdisciplinaire Groupe de recherche interdisciplinaire sur les maladies neuromusculaires
Jonquière, Quebec
Université du Québec à Chicoutimi
Saguenay, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions